Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apertus Pharmaceuticals is an FDA-inspected contract manufacturing company specializing in the development and manufacture of APIs and finished dose forms, including prescription and OTC products. In partnership with API Innovation Center and Glioblastoma Foundation, they manufacture lomustine for brain tumors to address US drug shortages, using continuous manufacturing technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apertus Pharmaceuticals.